Aquestive Therapeutics, Inc. (AQST)
Largest Insider Buys in Sector
AQST Stock Price History Chart
AQST Stock Performance
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.
Insider Activity of Aquestive Therapeutics, Inc.
Over the last 12 months, insiders at Aquestive Therapeutics, Inc. have bought $0 and sold $429,899 worth of Aquestive Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Aquestive Therapeutics, Inc. have bought $54,873 and sold $951,306 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $4,050 was made by Boyd Peter E. (SVP‑Bus. Process & Info. Tech.) on 2022‑06‑14.
List of Insider Buy and Sell Transactions, Aquestive Therapeutics, Inc.
| 2024-11-26 | Sale | Chief Operating Officer | 44 <0.0001% | $4.87 | $214 | -11.58% | ||
| 2024-03-15 | Sale | Chief Innovation/Tech Officer | 50,000 0.0672% | $6.00 | $300,000 | -31.86% | ||
| 2024-03-08 | Sale | Chief Innovation/Tech Officer | 25,000 0.0364% | $5.19 | $129,685 | -14.55% | ||
| 2022-06-14 | SVP-Bus. Process & Info. Tech. | 5,000 0.0107% | $0.81 | $4,050 | +11.38% | |||
| 2022-06-08 | Chief Innovation/Tech Officer | 45,871 0.1074% | $0.96 | $44,036 | +2.88% | |||
| 2022-06-08 | SVP-Bus. Process & Info. Tech. | 2,293 0.0054% | $0.96 | $2,201 | +2.88% | |||
| 2022-06-08 | General Counsel | 13,761 0.0322% | $0.96 | $13,211 | +2.88% | |||
| 2021-02-10 | Sale | 23,460 0.0662% | $6.75 | $158,355 | -38.78% | |||
| 2021-02-09 | Sale | 11,540 0.0328% | $6.75 | $77,895 | -38.02% | |||
| 2021-02-08 | Sale | 40,792 0.1131% | $6.50 | $265,148 | -37.03% | |||
| 2020-08-18 | Sale | 3,000 0.0088% | $8.00 | $24,000 | -37.84% | |||
| 2020-06-04 | Sale | 100,000 0.2958% | $5.11 | $510,620 | +2.92% | |||
| 2020-05-08 | Sale | 80,000 0.2312% | $5.00 | $400,000 | +3.69% | |||
| 2020-04-29 | Sale | 80,000 0.2256% | $4.50 | $360,000 | +12.42% | |||
| 2020-04-27 | Sale | 80,000 0.229% | $4.00 | $320,000 | +28.37% | |||
| 2020-04-14 | Sale | 80,000 0.2445% | $3.85 | $308,000 | +42.40% | |||
| 2020-03-16 | 4,000 0.0058% | $0.75 | $3,000 | +246.43% | ||||
| 2020-03-16 | 28,000 0.0837% | $1.54 | $43,249 | +246.43% | ||||
| 2019-08-27 | 4,000 0.0166% | $3.99 | $15,960 | +14.36% | ||||
| 2019-08-21 | 1,800 0.0068% | $3.81 | $6,858 | +7.92% |
Insider Historical Profitability
| Schobel Alexander Mark | Chief Innovation/Tech Officer | 984476 1.0797% | $3.71 | 4 | 9 | <0.0001% |
| Jung Cassie | Chief Operating Officer | 0 0% | $3.71 | 0 | 1 | |
| Kendall Keith J | 638964 0.7008% | $3.71 | 6 | 1 | <0.0001% | |
| BRATTON DOUGLAS K | 165000 0.181% | $3.71 | 1 | 0 | ||
| Maxwell John T. | 150614 0.1652% | $3.71 | 2 | 1 | <0.0001% | |
| Barber Daniel | 101959 0.1118% | $3.71 | 2 | 0 | <0.0001% | |
| Wood Theresa | 80765 0.0886% | $3.71 | 2 | 0 | <0.0001% | |
| Boyd Peter E. | SVP-Bus. Process & Info. Tech. | 59532 0.0653% | $3.71 | 5 | 0 | +43.71% |
| BRAENDER LORI J | General Counsel | 38761 0.0425% | $3.71 | 4 | 0 | +53.96% |
| Scibetta James S | 31635 0.0347% | $3.71 | 3 | 0 | +13.42% | |
| Marshall Ken W. | 1445 0.0016% | $3.71 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Bratton Capital Management L P | $41.79M | 10.78 | 9.81M | 0% | +$0 | 100 | |
| Vr Adviser Llc | $23.67M | 6.1 | 5.56M | New | +$23.67M | 1.15 | |
| The Vanguard Group | $13.81M | 3.56 | 3.24M | +71.65% | +$5.77M | <0.0001 | |
| Franklin Templeton Investments | $9.46M | 2.44 | 2.22M | New | +$9.46M | <0.01 | |
| Laurion Capital Management LP | $6.58M | 1.7 | 1.55M | New | +$6.58M | 0.05 | |
| Renaissance Technologies | $5.86M | 1.51 | 1.38M | +8.2% | +$444,324.97 | 0.01 | |
| BlackRock | $5.73M | 1.48 | 1.34M | +181.34% | +$3.69M | <0.0001 | |
| Monashee Investment Management LLC | $4.26M | 1.1 | 1M | New | +$4.26M | 0.37 | |
| Invesco | $3.82M | 0.99 | 897,512 | New | +$3.82M | <0.01 | |
| Blue Owl Capital Holdings Lp | $3.73M | 0.96 | 875,000 | New | +$3.73M | 0.31 | |
| Qube Research & Technologies | $3.62M | 0.93 | 849,213 | +1,176.11% | +$3.33M | <0.01 | |
| GHOST TREE CAPITAL LLC | $2.99M | 0.77 | 702,941 | New | +$2.99M | 0.04 | |
| Altium Capital Management Lp | $2.83M | 0.73 | 665,000 | New | +$2.83M | 0.33 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $2.61M | 0.67 | 612,949 | -27.56% | -$993,508.78 | 0.53 | |
| Susquehanna International Group | $2.56M | 0.66 | 601,989 | +1,473.54% | +$2.4M | <0.01 | |
| Woodline Partners LP | $2.56M | 0.66 | 600,592 | New | +$2.56M | 0.02 | |
| Velan Capital | $2.56M | 0.66 | 600,000 | New | +$2.56M | 1.39 | |
| Geode Capital Management | $2.29M | 0.59 | 538,456 | +8.8% | +$185,598.31 | <0.0001 | |
| Acadian Asset Management | $2.27M | 0.59 | 533,567 | -3.07% | -$72,003.15 | 0.01 | |
| Goldman Sachs | $2.24M | 0.58 | 526,422 | +1,626.03% | +$2.11M | <0.0001 | |
| Alyeska Investment Group L P | $2.13M | 0.55 | 500,000 | New | +$2.13M | 0.01 | |
| DAFNA Capital Management, LLC | $2.13M | 0.55 | 500,000 | New | +$2.13M | 0.05 | |
| Millennium Management LLC | $2.11M | 0.54 | 494,445 | +278.93% | +$1.55M | <0.01 | |
| Bracebridge Capital, LLC | $1.83M | 0.47 | 428,571 | 0% | +$0 | 0.36 | |
| LMR PARTNERS LLP | $1.77M | 0.46 | 414,480 | New | +$1.77M | 0.04 | |
| Stifel | $1.66M | 0.43 | 389,882 | New | +$1.66M | <0.01 | |
| Janney Montgomery Scott LLC | $1.46M | 0.38 | 341,860 | New | +$1.46M | 0.01 | |
| Hrt Financial Llc | $1.22M | 0.31 | 285,360 | New | +$1.22M | 0.01 | |
| Jane Street Capital | $1.12M | 0.29 | 263,140 | +68.59% | +$456,054.54 | <0.01 | |
| Legato Capital Management Llc | $1.06M | 0.27 | 248,503 | -27.03% | -$392,179.94 | 0.13 | |
| Latash Investments Llc | $1.04M | 0.27 | 243,134 | 0% | +$0 | 0.74 | |
| Citadel Advisors LLC | $955,403.00 | 0.25 | 224,273 | +33.64% | +$240,502.57 | <0.01 | |
| Man Group Plc | $946,086.00 | 0.24 | 222,086 | New | +$946,086.00 | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $934,640.00 | 0.24 | 219,399 | -16.13% | -$179,742.23 | <0.01 | |
| Bridgeway Capital Management | $821,567.00 | 0.21 | 192,856 | 0% | +$0 | 0.01 | |
| State Street | $773,774.00 | 0.2 | 181,637 | +19.86% | +$128,226.06 | <0.0001 | |
| Eam Investors | $461,119.00 | 0.12 | 108,244 | New | +$461,119.00 | 0.03 | |
| JPMorgan Chase | $436,305.00 | 0.11 | 102,419 | +100.6% | +$218,806.41 | <0.0001 | |
| Virtu Financial Llc | $438,000.00 | 0.11 | 102,836 | +219.66% | +$300,981.25 | 0.04 | |
| Northern Trust | $417,140.00 | 0.11 | 97,920 | +7.38% | +$28,661.33 | <0.0001 | |
| D. E. Shaw & Co. | $405,607.00 | 0.11 | 95,213 | New | +$405,607.00 | <0.0001 | |
| Ci Private Wealth Llc | $408,163.00 | 0.11 | 95,813 | -50% | -$408,163.00 | <0.0001 | |
| Morgan Stanley | $395,848.00 | 0.1 | 92,922 | +284.53% | +$292,905.03 | <0.0001 | |
| Marathon Trading Investment Management Llc | $383,400.00 | 0.1 | 90,000 | New | +$383,400.00 | 0.08 | |
| Cahill Wealth Management Llc | $367,268.00 | 0.1 | 86,213 | New | +$367,268.00 | 0.27 | |
| Advisor Group Holdings Inc | $365,422.00 | 0.09 | 85,780 | New | +$365,422.00 | <0.01 | |
| Diametric Capital Lp | $290,054.00 | 0.08 | 68,088 | New | +$290,054.00 | 0.12 | |
| Schonfeld Group | $267,302.00 | 0.07 | 62,747 | New | +$267,302.00 | <0.01 | |
| Beacon Pointe Advisors Llc | $255,600.00 | 0.07 | 60,000 | 0% | +$0 | <0.01 | |
| Two Sigma | $233,218.00 | 0.06 | 54,746 | -67.25% | -$478,879.46 | <0.0001 |